Pyrazine derivatives and pharmaceutical use thereof
US7407961B2 · kind B2 · utility
6Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2004 |
| Grant date | Aug 5, 2008 |
| Priority date | — |
| Expiry date | Mar 5, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pyrazine derivative of the following formula (I):or a salt thereof.The pyrazine compound (I) and a salt thereof of the present invention are adenosine antagonists and are useful for the prevention and/or treatment of depression, dementia (e.g. Alzheimer's disease, cerebrovascular dementia, dementia accompanying Parkinson's disease, etc.), Parkinson's disease, anxiety, pain, cerebrovascular disease (e.g. stroke, etc.), heart failure and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.